All News

According to National Vaccine Information Center, following analysis of reports submitted to the Vaccine Adverse Event Reporting System, a statistically significant increased risk of GBS and other serious adverse event reports was found when the HPV vaccine was coadministered with other vaccines.

The Teamsters Union has sent a letter to the investors of PharMerica, warning them that the long-term care provider's close ties with AmerisourceBergen might not be in the best interest of shareholders. According to the union, AmerisourceBergen has been linked to problems with drug counterfeiting, an alleged illegal rebate scheme, and loss of controlled substances in several of its warehouses.

Many hospitals have instituted paper-based systems to capture inpatient prescription information to avoid adverse drug events, but one community-based hospital has gone a step further to adopt an automated medication reconciliation program. Fauquier Health System in northern Virginia is currently testing a pilot system that electronically provides the hospital staff with a patient's medication history.

Proposed rules from the Health Resources and Services Administration to make children's hospitals eligible for 340B are moving slowly. And final rules from the Centers for Medicare and Medicaid Services will boost costs while cutting reimbursement.

The National Comprehensive Cancer Network recently updated its guidelines for Non-Hodgkin's Lymphoma to include new therapeutic options, as well as changes to diagnostic criteria and staging.

The four leading infusion pump manufacturers all report brisk sales of smart pumps, but many users are evading the software dosing safeguards that make pumps smart.

Ready or not, electonic pedigree is coming. But bumps in the road area already rocking the pharmaceutical world. The biggest bump: vague definitions and conflicting exptectations.

CMS announced that it would release NPI number data beginning Sept. 4, at which point all data that are disclosable under the Freedom of Information Act will be made available to the public.

Products encompassing newly approved Rx drugs and generics, plus health and beauty care, home health care, and other items.

While drug-resistant infections have been multiplying, there has been a mere trickle of new antibiotics coming down the pipeline. The tide may be changing; there are 30 or more antibiotics in development.